A Board Member Bought Over $300,000 of Abbott Labs

Page 1 of 2

A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and $33.90. He now owns a little over 34m000 shares of the stock, so this is a significant purchase in percentage terms. Studies show that insider purchases are bullish signs (see our analysis of studies on insider trading). We think that this is because an insider must be confident enough in the company’s prospects to ignore the benefits of diversification before buying the stock.

Abbott Laboratories is a $53 billion market provider of pharmaceuticals (including generics), diagnostic systems, and medical devices. Last quarter it experienced a 4% increase in revenue compared to the fourth quarter of 2011. With operating expenses up only slightly- thanks in part to a small reduction in R&D- operating income grew 16% from its levels a year earlier. While earnings were down, this was due to a large loss on extinguishment of debt that we think we can assume is in the best interests of Abbott Labs as well as non-recurring.

MILLENNIUM MANAGEMENT

The stock trades at 9 times trailing earnings, though judging from analyst expectations it appears that is based on abnormally high net income in 2012. Consensus is for $2.02 in EPS this year, implying a current-year P/E of 17. We would say that from a value perspective that would be a decent multiple assuming moderate earnings growth over the next several years, and so we could see a value investor doing further research on the stock. While many pharmaceutical companies are thought of as income stocks, Abbott Laboratories is not quite optimal there: the beta is indeed fairly low at 0.5, but the dividend yield is less than 2%.

Billionaire Israel Englander’s Millennium Management increased its stake in Abbott Labs during the third quarter to a total of about 940,000 shares (find Englander’s favorite stocks). Citadel Investment Group, which is managed by billionaire Ken Griffin, reported a position of 1.6 million shares on its own 13F (check out Griffin’s stock picks). Orbimed Advisors, a healthcare focused fund run by Samuel Isaly and his team, was also buying the stock and closed September with 2.5 million shares in its portfolio (research more stocks that Orbimed was buying).

How does Abbott compare to similar companies?

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!